Navigation Links
ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City
Date:2/3/2009

SANFORD, Fla., Feb. 3 /PRNewswire/ -- .decimal, Inc. announced today that it has signed an agreement with ProCure Treatment Centers, Inc. to supply patient-specific devices for its proton therapy facility in Oklahoma City, Oklahoma.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

".decimal is excited to have a formal agreement signed with ProCure to be their preferred outsource provider of custom, patient-specific devices utilizing our patented, internet-based manufacturing solution," says Richard Sweat, CEO and President of .decimal.

This agreement calls for proton range compensators and apertures to be manufactured in Sanford, Florida and shipped to the facility in Oklahoma within 24-72 hours. Mark Mills, Senior Vice President of Sales and Marketing for .decimal says, "Signing with ProCure just further strengthens the commitment we have made to the proton therapy industry and specifically to their state-of-the-art facility in Oklahoma City."

.decimal, Inc. has been supplying patient-specific medical devices, as well as other custom machining projects for the University of Florida Proton Therapy Institute since June of 2007. This partnership continues to demonstrate why .decimal, Inc. is the industry leader in partnering with proton therapy facilities worldwide.

"We are proud to partner with ProCure as they roll out proton therapy around the world," says Sweat.

As well as working with proton facilities, .decimal, Inc. supplies close to 200 radiation oncology facilities nationwide with patient-specific devices used in Compensator-Based Intensity Modulated Radiation Therapy (IMRT), including 21st Century Oncology sites and H. Lee Moffitt Cancer and Research Center.

With the addition of the facility in Oklahoma, .decimal will continue to develop new and innovative technologies which will increase patient throughput while providing high quality devices to the patients in Oklahoma City.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced Compensator-Based IMRT delivery, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
4. ProCure Selects IMPAC as Provider of Oncology Information Systems
5. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
6. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
7. Signalife Continues to Procure Purchase Orders, Revenues
8. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
9. Traditional Risk Factors Often Miss Heart Disease Warning Signs
10. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
11. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):